Attached files

file filename
EX-32.1 - EX-32.1 - Replimune Group, Inc.a19-26434_3ex32d1.htm
EX-31.2 - EX-31.2 - Replimune Group, Inc.a19-26434_3ex31d2.htm
EX-31.1 - EX-31.1 - Replimune Group, Inc.a19-26434_3ex31d1.htm
EX-10.2 - EX-10.2 - Replimune Group, Inc.a19-26434_3ex10d2.htm
10-Q - 10-Q - Replimune Group, Inc.a19-26434_310q.htm

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Replimune Group, Inc. (the “Company”) for the period ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Jean Franchi, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 13, 2020

By:

/s/ Jean Franchi

 

 

Jean Franchi

 

 

Chief Financial Officer

 

 

(Principal Financial Officer)